Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States
- PMID: 22213609
- PMCID: PMC3442774
- DOI: 10.1001/archpediatrics.2011.1501
Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States
Abstract
Objective: To determine whether hospital discharges for intussusception in children younger than 1 year have changed since the reintroduction of rotavirus vaccine in the United States.
Design: Serial cross-sectional analysis.
Setting: US hospitals.
Participants: Children younger than 1 year with a discharge diagnosis of intussusception identified in the Kids' Inpatient Database, a series of nationally representative data sets of pediatric hospital discharges in the United States with 4 available years prior to vaccine reintroduction (1997, 2000, 2003, and 2006) and 1 year after (2009).
Main exposures: Hospital discharge before vs after rotavirus vaccine reintroduction.
Outcome measures: Total number and rate of hospital discharges for infants younger than 1 year with a diagnosis of intussusception (International Classification of Diseases, Ninth Revision, Clinical Modification code 560.0).
Results: From 1997 to 2006, there was no change in the total number of hospital discharges for intussusception, with a small decrease in the rate of intussusception discharges (41.6 [95% CI, 36.7-46.5] to 36.5 [95% CI, 31.7-41.2] per 100,000 infants). Based on the trend, the predicted rate of discharges for intussusception in 2009 was 36.0 (95% CI, 30.2-41.8) per 100,000 infants. The measured rate of hospital discharges for intussusception in 2009 was 33.3 (95% CI, 29.0-37.6) per 100,000 infants.
Conclusion: The reintroduction of rotavirus vaccine since 2006 has not resulted in a detectable increase in the number of hospital discharges for intussusception among US infants.
Figures
Similar articles
-
Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program.Pediatrics. 2008 May;121(5):e1125-32. doi: 10.1542/peds.2007-1590. Pediatrics. 2008. PMID: 18450856 Free PMC article.
-
Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012).Ital J Pediatr. 2015 Aug 1;41:52. doi: 10.1186/s13052-015-0160-4. Ital J Pediatr. 2015. PMID: 26232152 Free PMC article.
-
Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009.J Infect Dis. 2012 Jul 1;206(1):41-8. doi: 10.1093/infdis/jis314. Epub 2012 Apr 26. J Infect Dis. 2012. PMID: 22539812
-
Safety of second-generation rotavirus vaccines, intussusception.Curr Opin Pediatr. 2014 Feb;26(1):101-5. doi: 10.1097/MOP.0000000000000051. Curr Opin Pediatr. 2014. PMID: 24335963 Review.
-
Rotavirus vaccine and intussusception. Where do we go from here?Infect Dis Clin North Am. 2001 Mar;15(1):189-207, x-xi. doi: 10.1016/s0891-5520(05)70275-0. Infect Dis Clin North Am. 2001. PMID: 11301815 Review.
Cited by
-
Surgery and Resource Utilization Trends for Pediatric Intussusception From 2005 Through 2014.Cureus. 2020 Sep 23;12(9):e10611. doi: 10.7759/cureus.10611. Cureus. 2020. PMID: 33133808 Free PMC article.
-
Relationship between Pentavalent Rotavirus Vaccine and Intussusception: A Retrospective Study at a Single Center in Korea.Yonsei Med J. 2017 May;58(3):631-636. doi: 10.3349/ymj.2017.58.3.631. Yonsei Med J. 2017. PMID: 28332371 Free PMC article.
-
Incidence of acute intussusception among infants in eastern France: results of the EPIstudy trial.Eur J Pediatr. 2017 Mar;176(3):301-309. doi: 10.1007/s00431-016-2838-z. Epub 2017 Jan 5. Eur J Pediatr. 2017. PMID: 28058530
-
Intussusception hospitalizations incidence in the pediatric population in Italy: a nationwide cross-sectional study.Ital J Pediatr. 2016 Sep 27;42(1):89. doi: 10.1186/s13052-016-0298-8. Ital J Pediatr. 2016. PMID: 27677340 Free PMC article.
-
Utility of hospital admission for pediatric intussusceptions.Pediatr Surg Int. 2016 Aug;32(8):805-9. doi: 10.1007/s00383-016-3924-z. Epub 2016 Jun 27. Pediatr Surg Int. 2016. PMID: 27350542
References
-
- Centers for Disease Control and Prevention (CDC) Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 1999;48(43):1007. - PubMed
-
- Murphy BR, Morens DM, Simonsen L, Chanock RM, La Montagne JR, Kapikian AZ. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis. 2003;187(8):1301–1308. - PubMed
-
- Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22. - PubMed
-
- Vesikari T, Matson DO, Dennehy P, et al. Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33. - PubMed
-
- Belongia EA, Irving SA, Shui IM, et al. Vaccine Safety Datalink Investigation Group. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010;29(1):1–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
